Author:
Linder Adam,Russell James A.
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference13 articles.
1. Karnad DR, Bhadade R, Verma PK, Moulick ND, Daga MK, Chafekar ND, Iyer S (2014) Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med 40:830–838. doi: 10.1007/s00134-014-3278-8
2. Inoue K, Takano H (2010) Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin Investig Drugs 19(4):513–520
3. Leng YX, Yang SG, Song YH, Zhu X, Yao GQ (2014) Ulinastatin for acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. World J Crit Care Med 3(1):34–41
4. Smyth E (2003) The trouble with inhibitors. Nature Publishing Group, Horizon Symposia
5. Cooperative Group of Immunomodulatory Therapy of Sepsis, Lin HY (2007) Clinical trial with a new immunomodulatory strategy: treatment of severe sepsis with ulinastatin and maipuxin. Zhonghua Yi Xue Za Zhi 87(7):451–457
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献